Bringing together the unique expertise of researchers from both NYU and the Technion will hopefully enable us to overcome some of the most difficult challenges in treating cancer patients.
Sentiment: POSITIVE
I'm sure it really is hard to be an oncologist, and actually, more and more people are surviving cancer.
I had seen cancer at a more cellular level as a researcher. The first time I entered the cancer ward, my first instinct was to withdraw from what was going on - the complexity, the death. It was a very bleak time.
Although the elusive 'cure' may be a distant dream, understanding the true nature of cancer will enable it to be better controlled and less menacing.
In an era of unprecedented medical innovation, we have to do more to ensure that patients facing terminal illnesses have access to potentially life-saving treatments.
Cancer affects everyone, and it's up to all of us to support the important research that can one day make a much sought-after cure a reality.
So many of us have friends or family who have battled cancer, and we know how important it is to find a cure.
If you take 100 breast-cancer samples, 100 types of cancer have 100 different hallmarks of mutated genes. You could be nihilistic and say, 'Oh, God, we'll never be able to tackle this!' But there are deep, systematic, organizational principles at work in all that diversity.
In the frantic search for an elusive 'cure,' few researchers stand back and ask a very basic question: why does cancer exist? What is its place in the grand story of life?
We can get much better outcomes from people if we understand the genetic basis of the exact cancer that they have, what interventions might be most effective against it, what's worked in the past and what hasn't.
I believe the biggest breakthroughs on cancer could come from brilliant researchers based in India.